Advances in rheumatology (London, England)HumansLupus ErythematosusSystemicFemaleMale
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort.
Priscila Dias Cardoso Ribeiro, Flavia Maria Matos Melo Campos Peixoto, Edgard Torres Dos Reis-Neto, Gecilmara Salviato Pileggi, Nancy Cristina Junqueira Bellei, Marcelo de Medeiros Pinheiro, Vanessa de Oliveira Magalhães, Erika Biegelmeyer, André Gustavo Cunha Trolese, Alexandre Wagner Silva de Souza, Cristiane Kayser, Valéria Valim, Ketty Lysie Libardi Lira Machado, Maressa Barbosa Beloni Lirio, Juliana Ribeiro de Oliveira
Published: 202510.1186/s42358-025-00498-9
Abstract
BACKGROUND: The immune response and safety using different COVID-19 vaccine platforms in patients with immune mediated rheumatic diseases is still uncertain. The objective of this study is to compare the immunogenicity and safety after two doses of B…
Preview only. Read the full abstract at the source